Ellevest Inc’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-142
Closed -$23.9K 1336
2023
Q1
$23.9K Sell
142
-76
-35% -$13.6K ﹤0.01% 810
2022
Q4
$36.9K Sell
218
-128
-37% -$23.2K ﹤0.01% 695
2022
Q3
$65K Buy
346
+289
+507% +$60.9K 0.01% 512
2022
Q2
$9K Buy
57
+3
+6% +$474 ﹤0.01% 912
2022
Q1
$10K Buy
54
+42
+350% +$7.98K ﹤0.01% 893
2021
Q4
$3K Buy
12
+2
+20% +$539 ﹤0.01% 1108
2021
Q3
$3K Buy
+10
New +$2.56K ﹤0.01% 1078
2021
Q2
Sell
-23
Closed -$4K 1389
2021
Q1
$4K Buy
23
+13
+130% +$2.67K ﹤0.01% 959
2020
Q4
$2K Buy
+10
New +$1.82K ﹤0.01% 993

Other funds holding RGEN

Ellevest Inc's RGEN Position: Q2 2023 in Review

Ellevest Inc sold out of Repligen (RGEN) in Q2 2023, closing a stake of 142 shares — an estimated $23.9K sold.

Ellevest Inc first reported a position in RGEN in Q4 2020 and held it in 9 quarters. The position peaked at $65K in Q3 2022. 446 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.

  • Ellevest Inc reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 142 Repligen shares in Q2 2023, an estimated $23.9K.
  • Ellevest Inc first reported a position in Repligen in Q4 2020 and held it in 9 quarters.
  • Ellevest Inc's Repligen position peaked at $65K in Q3 2022.
  • 446 funds tracked by Wall St. Rank held Repligen as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.